Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2012
FDA regulation of cardiovascular devices and opportunities for improvement.
Историческая статьяСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dhruva Sanket S, Redberg Rita F
Аннотация
Medical devices are of increasing importance in cardiovascular disease and have made important contributions to patient care. These devices continue to evolve with increasing complexity. FDA regulation of medical devices involves increased stringency for higher risk and novel devices. However, there are some current opportunities to strengthen the FDA's pre-approval regulatory process and improve post-marketing surveillance. This article reviews FDA regulation of cardiovascular devices and offers suggestions for strengthening the process while focusing on examples relevant to cardiac electrophysiologists.
Предметные рубрики MeSH
CardiologyCardiovascular DiseasesClinical Trials as TopicDefibrillators, ImplantableDevice ApprovalEquipment DesignEquipment SafetyHistory, 20th CenturyHumansMedical Device LegislationMedical Device RecallsPacemaker, ArtificialProduct Surveillance, PostmarketingUnited StatesUnited States Food and Drug AdministrationVascular Surgical Procedures